• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Unsaturated fatty acids

Introduction to (Z)-2-Methyl-2-butenoic Acid Potassium Salt (CAS No. 65885-66-7)

The compound (Z)-2-Methyl-2-butenoic Acid Potassium Salt, identified by its CAS number 65885-66-7, is a significant chemical entity in the field of pharmaceuticals and biochemical research. This compound, a potassium salt derivative of (Z)-2-methyl-2-butenoic acid, has garnered attention due to its unique structural properties and potential applications in various scientific domains.

In recent years, the study of organic acids and their derivatives has seen considerable advancements, particularly in understanding their roles in biochemical pathways and drug development. The (Z)-isomer of 2-methyl-2-butenoic acid is of particular interest due to its geometric configuration, which can influence its reactivity and interaction with biological targets. The potassium salt form enhances solubility and stability, making it a valuable intermediate in synthetic chemistry and pharmaceutical formulations.

Current research indicates that derivatives of (Z)-2-methyl-2-butenoic acid are being explored for their potential in modulating various enzymatic activities and signaling pathways. For instance, studies have suggested that this compound may interact with specific receptors or enzymes involved in inflammation and metabolic processes. The potassium salt form is particularly useful in these studies due to its improved bioavailability and reduced toxicity compared to the free acid form.

The pharmaceutical industry has shown interest in developing novel therapeutic agents based on structurally diverse organic acids. The unique properties of (Z)-2-Methyl-2-butenoic Acid Potassium Salt make it a promising candidate for further investigation. Researchers are exploring its potential applications in the treatment of metabolic disorders, inflammatory conditions, and even as a precursor for more complex drug molecules.

One of the key advantages of using potassium salt derivatives in pharmaceutical research is their enhanced solubility in aqueous solutions. This property is crucial for formulating drugs that require oral or intravenous administration. The solubility profile of (Z)-2-Methyl-2-butenoic Acid Potassium Salt allows for easier integration into drug delivery systems, potentially improving patient compliance and therapeutic outcomes.

Moreover, the compound's stability under various conditions makes it a reliable choice for industrial applications. In synthetic chemistry, it serves as an effective building block for more complex molecules. Its reactivity and compatibility with other chemical entities have been leveraged in the synthesis of novel compounds with potential pharmacological activity.

The biochemical significance of (Z)-2-methyl-2-butenoic acid derivatives lies in their ability to influence multiple biological pathways. Research has indicated that these compounds can modulate the activity of key enzymes involved in fatty acid metabolism, which is relevant to conditions such as obesity and type 2 diabetes. Additionally, their interaction with inflammatory pathways suggests potential applications in anti-inflammatory therapies.

In conclusion, the compound (Z)-2-Methyl-2-butenoic Acid Potassium Salt (CAS No. 65885-66-7) represents a fascinating area of study with significant implications for pharmaceutical development and biochemical research. Its unique structural features, combined with its enhanced solubility and stability as a potassium salt derivative, position it as a valuable asset in both academic research and industrial applications. As further studies continue to uncover its potential benefits, this compound is likely to play an increasingly important role in the advancement of therapeutic agents targeting various human health conditions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)